RS
CDNA icon

R Squared’s CareDx CDNA Stock Holding History

R Squared’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-880
Closed -$18.8K – 512
2024
Q4 		$18.8K Buy
+880
New +$21.4K 0.02% 906

Other funds holding CDNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

R Squared's CDNA Position: Q1 2025 in Review

R Squared sold out of CareDx (CDNA) in Q1 2025, closing a stake of 880 shares — an estimated $18.8K sold.

R Squared first reported a position in CDNA in Q4 2024 and held it in 1 quarter. The position peaked at $18.8K in Q4 2024. 218 funds tracked by Wall St. Rank hold CDNA as of Q1 2025.

  • R Squared reported no remaining CareDx position as of Q1 2025 after selling out during the quarter.
  • R Squared sold 880 CareDx shares in Q1 2025, an estimated $18.8K.
  • R Squared first reported a position in CareDx in Q4 2024 and held it in 1 quarter.
  • R Squared's CareDx position peaked at $18.8K in Q4 2024.
  • 218 funds tracked by Wall St. Rank held CareDx as of Q1 2025.

Based on R Squared's 13F filing for Q1 2025, filed 9 May 2025.